BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stanski NL, Wong HR. Prognostic and predictive enrichment in sepsis. Nat Rev Nephrol 2020;16:20-31. [PMID: 31511662 DOI: 10.1038/s41581-019-0199-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Bodinier M, Peronnet E, Brengel-Pesce K, Conti F, Rimmelé T, Textoris J, Vedrine C, Quemeneur L, Griffiths AD, Tan LK, Venet F, Maucort-Boulch D, Monneret G; REALISM study group. Monocyte Trajectories Endotypes Are Associated With Worsening in Septic Patients. Front Immunol 2021;12:795052. [PMID: 34912347 DOI: 10.3389/fimmu.2021.795052] [Reference Citation Analysis]
2 Dinc G, Gonen ZB, Soltani J, Doganay M. Sepsis and Septic Shock; Current Treatment Dilemma and Role of Stem Cell Therapy in Pediatrics. Arch Pediatr Infect Dis 2021;9. [DOI: 10.5812/pedinfect.105301] [Reference Citation Analysis]
3 Li X, Yao L, Zeng X, Hu B, Zhang X, Wang J, Zhu R, Yu Q. miR-30c-5p Alleviated Pyroptosis During Sepsis-Induced Acute Kidney Injury via Targeting TXNIP. Inflammation 2021;44:217-28. [PMID: 32892306 DOI: 10.1007/s10753-020-01323-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Mithal LB, Arshad M, Swigart LR, Khanolkar A, Ahmed A, Coates BM. Mechanisms and modulation of sepsis-induced immune dysfunction in children. Pediatr Res 2021. [PMID: 34952937 DOI: 10.1038/s41390-021-01879-8] [Reference Citation Analysis]
5 Reijnders TDY, Peters-Sengers H, van Vught LA, Uhel F, Bonten MJM, Cremer OL, Schultz MJ, Stuiver MM, van der Poll T; MARS consortium. Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation. Crit Care 2022;26:151. [PMID: 35610649 DOI: 10.1186/s13054-022-04016-x] [Reference Citation Analysis]
6 Odum JD, Wong HR, Stanski NL. A Precision Medicine Approach to Biomarker Utilization in Pediatric Sepsis-Associated Acute Kidney Injury. Front Pediatr 2021;9:632248. [PMID: 33937146 DOI: 10.3389/fped.2021.632248] [Reference Citation Analysis]
7 Nunnally ME, Ferrer R, Martin GS, Martin-Loeches I, Machado FR, De Backer D, Coopersmith CM, Deutschman CS; Surviving Sepsis Campaign Reasearch Committee. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med Exp 2021;9:34. [PMID: 34212256 DOI: 10.1186/s40635-021-00400-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 de Nooijer AH, Grondman I, Lambden S, Kooistra EJ, Janssen NAF, Kox M, Pickkers P, Joosten LAB, van de Veerdonk FL, Derive M, Gibot S, Netea MG; RCI-COVID-19 study group. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19. Biosci Rep 2021;41:BSR20210940. [PMID: 34195785 DOI: 10.1042/BSR20210940] [Reference Citation Analysis]
9 Wong HR, Caldwell JT, Cvijanovich NZ, Weiss SL, Fitzgerald JC, Bigham MT, Jain PN, Schwarz A, Lutfi R, Nowak J, Allen GL, Thomas NJ, Grunwell JR, Baines T, Quasney M, Haileselassie B, Lindsell CJ. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Sci Transl Med 2019;11:eaax9000. [PMID: 31723040 DOI: 10.1126/scitranslmed.aax9000] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
10 Yu C, Zhu X, Zheng C, Luo Y, Wang F, Gao Y, Wu H, Sun X, Kong X. Methyl Diet Enhanced Sepsis-Induced Mortality Through Altering Gut Microbiota. J Inflamm Res 2021;14:3107-21. [PMID: 34276224 DOI: 10.2147/JIR.S305202] [Reference Citation Analysis]
11 Stanski NL, Fuhrman D, Basu RK. Controversies in paediatric acute kidney injury and continuous renal replacement therapy: can paediatric care lead the way to precision acute kidney injury medicine? Curr Opin Crit Care 2021;27:604-10. [PMID: 34561357 DOI: 10.1097/MCC.0000000000000888] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity 2021;54:2450-64. [PMID: 34758337 DOI: 10.1016/j.immuni.2021.10.012] [Reference Citation Analysis]
13 Francois B, Lambden S, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Grouin JM, Garaud JJ, Salcedo-Magguilli M, Levy M, Laterre PF. Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial. BMJ Open 2021;11:e042921. [PMID: 34233965 DOI: 10.1136/bmjopen-2020-042921] [Reference Citation Analysis]
14 Schrijver IT, Karakike E, Théroude C, Baumgartner P, Harari A, Giamarellos-Bourboulis EJ, Calandra T, Roger T. High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure. Intensive Care Med Exp 2022;10:5. [PMID: 35146585 DOI: 10.1186/s40635-022-00431-0] [Reference Citation Analysis]
15 Donovan K, Shah A, Day J, McKechnie SR. Adjunctive treatments for the management of septic shock - a narrative review of the current evidence. Anaesthesia 2021;76:1245-58. [PMID: 33421029 DOI: 10.1111/anae.15369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cheng S, Kerr KF, Thiessen-Philbrook H, Coca SG, Parikh CR. BioPETsurv: Methodology and open source software to evaluate biomarkers for prognostic enrichment of time-to-event clinical trials. PLoS One 2020;15:e0239486. [PMID: 32946505 DOI: 10.1371/journal.pone.0239486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Baillet N, Reynard S, Perthame E, Hortion J, Journeaux A, Mateo M, Carnec X, Schaeffer J, Picard C, Barrot L, Barron S, Vallve A, Duthey A, Jacquot F, Boehringer C, Jouvion G, Pietrosemoli N, Legendre R, Dillies MA, Allan R, Legras-Lachuer C, Carbonnelle C, Raoul H, Baize S. Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques. Commun Biol 2021;4:27. [PMID: 33398113 DOI: 10.1038/s42003-020-01543-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Shrestha GS, Paneru HR, Vincent JL. Precision medicine for COVID-19: a call for better clinical trials. Crit Care 2020;24:282. [PMID: 32487260 DOI: 10.1186/s13054-020-03002-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
19 Garnica O, Gómez D, Ramos V, Hidalgo JI, Ruiz-Giardín JM. Diagnosing hospital bacteraemia in the framework of predictive, preventive and personalised medicine using electronic health records and machine learning classifiers. EPMA J 2021;:1-17. [PMID: 34484472 DOI: 10.1007/s13167-021-00252-3] [Reference Citation Analysis]
20 Stanski NL, Stenson EK, Cvijanovich NZ, Weiss SL, Fitzgerald JC, Bigham MT, Jain PN, Schwarz A, Lutfi R, Nowak J, Allen GL, Thomas NJ, Grunwell JR, Baines T, Quasney M, Haileselassie B, Wong HR. PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock. Am J Respir Crit Care Med 2020;201:848-55. [PMID: 31916857 DOI: 10.1164/rccm.201911-2187OC] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
21 Chicco D, Jurman G. Survival prediction of patients with sepsis from age, sex, and septic episode number alone. Sci Rep 2020;10:17156. [PMID: 33051513 DOI: 10.1038/s41598-020-73558-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Stoppe C, Wendt S, Mehta NM, Compher C, Preiser JC, Heyland DK, Kristof AS. Biomarkers in critical care nutrition. Crit Care 2020;24:499. [PMID: 32787899 DOI: 10.1186/s13054-020-03208-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
23 Wong HR. Pediatric sepsis biomarkers for prognostic and predictive enrichment. Pediatr Res 2021. [PMID: 34127800 DOI: 10.1038/s41390-021-01620-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Shah FA, Meyer NJ, Angus DC, Awdish R, Azoulay É, Calfee CS, Clermont G, Gordon AC, Kwizera A, Leligdowicz A, Marshall JC, Mikacenic C, Sinha P, Venkatesh B, Wong HR, Zampieri FG, Yende S. A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2021;204:891-901. [PMID: 34652268 DOI: 10.1164/rccm.202108-1908ST] [Reference Citation Analysis]
25 Wong HR, Hart KW, Lindsell CJ, Sweeney TE. External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients. Crit Care Med 2021;49:e98-e101. [PMID: 33156120 DOI: 10.1097/CCM.0000000000004709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Xu N, Guo H, Li X, Zhao Q, Li J. A Five-Genes Based Diagnostic Signature for Sepsis-Induced ARDS. Pathol Oncol Res 2021;27:580801. [PMID: 34393665 DOI: 10.3389/pore.2021.580801] [Reference Citation Analysis]
27 Mendelson AA, Lansdell C, Fox-Robichaud AE, Liaw P, Arora J, Cailhier JF, Cepinskas G, Charbonney E, Dos Santos C, Dwivedi D, Ellis CG, Fergusson D, Fiest K, Gill SE, Hendrick K, Hunniford VT, Kowalewska PM, Krewulak K, Lehmann C, Macala K, Marshall JC, Mawdsley L, McDonald B, McDonald E, Medeiros SK, Muniz VS, Osuchowski M, Presseau J, Sharma N, Sohrabipour S, Sunohara-Neilson J, Vázquez-Grande G, Veldhuizen RAW, Welsh D, Winston BW, Zarychanski R, Zhang H, Zhou J, Lalu MM; Sepsis Canada’s National Preclinical Sepsis Platform. National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis research. Intensive Care Med Exp 2021;9:14. [PMID: 33738642 DOI: 10.1186/s40635-020-00366-4] [Reference Citation Analysis]
28 Steinhagen F, Schmidt SV, Schewe JC, Peukert K, Klinman DM, Bode C. Immunotherapy in sepsis - brake or accelerate? Pharmacol Ther 2020;208:107476. [PMID: 31931100 DOI: 10.1016/j.pharmthera.2020.107476] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
29 Beitler JR, Thompson BT, Baron RM, Bastarache JA, Denlinger LC, Esserman L, Gong MN, LaVange LM, Lewis RJ, Marshall JC, Martin TR, McAuley DF, Meyer NJ, Moss M, Reineck LA, Rubin E, Schmidt EP, Standiford TJ, Ware LB, Wong HR, Aggarwal NR, Calfee CS. Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med 2021:S2213-2600(21)00157-0. [PMID: 34310901 DOI: 10.1016/S2213-2600(21)00157-0] [Reference Citation Analysis]
30 DeMerle KM, Angus DC, Baillie JK, Brant E, Calfee CS, Carcillo J, Chang CH, Dickson R, Evans I, Gordon AC, Kennedy J, Knight JC, Lindsell CJ, Liu V, Marshall JC, Randolph AG, Scicluna BP, Shankar-Hari M, Shapiro NI, Sweeney TE, Talisa VB, Tang B, Thompson BT, Tsalik EL, van der Poll T, van Vught LA, Wong HR, Yende S, Zhao H, Seymour CW. Sepsis Subclasses: A Framework for Development and Interpretation. Crit Care Med 2021;49:748-59. [PMID: 33591001 DOI: 10.1097/CCM.0000000000004842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
31 Aldewereld ZT, Zhang LA, Urbano A, Parker RS, Swigon D, Banerjee I, Gómez H, Clermont G. Identification of Clinical Phenotypes in Septic Patients Presenting With Hypotension or Elevated Lactate. Front Med 2022;9:794423. [DOI: 10.3389/fmed.2022.794423] [Reference Citation Analysis]
32 Grolleau F, Porcher R, Barbar S, Hajage D, Bourredjem A, Quenot JP, Dreyfuss D, Gaudry S. Personalization of renal replacement therapy initiation: a secondary analysis of the AKIKI and IDEAL-ICU trials. Crit Care 2022;26:64. [PMID: 35313942 DOI: 10.1186/s13054-022-03936-y] [Reference Citation Analysis]
33 Miao H, Chen S, Ding R. Evaluation of the Molecular Mechanisms of Sepsis Using Proteomics. Front Immunol 2021;12:733537. [PMID: 34745104 DOI: 10.3389/fimmu.2021.733537] [Reference Citation Analysis]
34 Wang S, Tan KS, Beng H, Liu F, Huang J, Kuai Y, Zhang R, Tan W. Protective effect of isosteviol sodium against LPS-induced multiple organ injury by regulating of glycerophospholipid metabolism and reducing macrophage-driven inflammation. Pharmacol Res 2021;172:105781. [PMID: 34302975 DOI: 10.1016/j.phrs.2021.105781] [Reference Citation Analysis]
35 Cummings MJ, Bakamutumaho B, Price A, Owor N, Kayiwa J, Namulondo J, Byaruhanga T, Muwanga M, Nsereko C, Sameroff S, Tokarz R, Wong W, Shah SS, Larsen MH, Lipkin WI, Lutwama JJ, O’donnell MR. Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in Uganda. Crit Care 2022;26. [DOI: 10.1186/s13054-022-03907-3] [Reference Citation Analysis]
36 Hong J, Mo S, Gong F, Lin Z, Cai H, Shao Z, Yang X, Sun R, Zhang Q, Liu J. lncRNA-SNHG14 Plays a Role in Acute Lung Injury Induced by Lipopolysaccharide through Regulating Autophagy via miR-223-3p/Foxo3a. Mediators Inflamm 2021;2021:7890288. [PMID: 34539244 DOI: 10.1155/2021/7890288] [Reference Citation Analysis]
37 Tran A, Fernando SM, Rochwerg B, Seymour CW, Cook DJ. Characterizing systematic challenges in sample size determination for sepsis trials. Intensive Care Med 2022. [PMID: 35412128 DOI: 10.1007/s00134-022-06691-4] [Reference Citation Analysis]
38 Venet F, Demaret J, Gossez M, Monneret G. Myeloid cells in sepsis-acquired immunodeficiency. Ann N Y Acad Sci 2020. [PMID: 32202669 DOI: 10.1111/nyas.14333] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
39 Trovato G. SEPSIS. Educational and Best Practice Frontiers. Beyond the Boundaries of Fatality, Enhancing Clinical Skills and Precision Medicine. Ther Clin Risk Manag 2020;16:87-93. [PMID: 32103969 DOI: 10.2147/TCRM.S232530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Schuurman AR, Reijnders TDY, Kullberg RFJ, Butler JM, van der Poll T, Wiersinga WJ. Sepsis: deriving biological meaning and clinical applications from high-dimensional data. Intensive Care Med Exp 2021;9:27. [PMID: 33961170 DOI: 10.1186/s40635-021-00383-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Shen K, Jia Y, Wang X, Zhang J, Liu K, Wang J, Cai W, Li J, Li S, Zhao M, Wang Y, Hu D. Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophages. Free Radic Biol Med 2021;165:54-66. [PMID: 33476797 DOI: 10.1016/j.freeradbiomed.2021.01.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
42 Ji L, He Q, Liu Y, Deng Y, Xie M, Luo K, Cai X, Zuo Y, Wu W, Li Q, Zhou R, Li T, Rauf A. Ketone Body β-Hydroxybutyrate Prevents Myocardial Oxidative Stress in Septic Cardiomyopathy. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/2513837] [Reference Citation Analysis]
43 Bagshaw SM, Al-Khafaji A, Artigas A, Davison D, Haase M, Lissauer M, Zacharowski K, Chawla LS, Kwan T, Kampf JP, McPherson P, Kellum JA. External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury. Crit Care 2021;25:185. [PMID: 34059102 DOI: 10.1186/s13054-021-03618-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Zhang X, Zhang M, Zhou M, Zhang T, Gao Y, Li S, Lin Y, Cai X. Tetrahedral-Framework Nucleic Acids Carry Small Interfering RNA to Downregulate Toll-Like Receptor 2 Gene Expression for the Treatment of Sepsis. ACS Appl Mater Interfaces 2022;14:6442-52. [PMID: 35080860 DOI: 10.1021/acsami.1c23708] [Reference Citation Analysis]
45 Chen ZD, Hu BC, Shao XP, Hong J, Zheng Y, Zhang R, Shao ZQ, Liu JQ, Yang XH, Sun RH, Mo SJ. Ascorbate uptake enables tubular mitophagy to prevent septic AKI by PINK1-PARK2 axis. Biochem Biophys Res Commun 2021;554:158-65. [PMID: 33798942 DOI: 10.1016/j.bbrc.2021.03.103] [Reference Citation Analysis]
46 Qian L, Yin X, Ji J, Chen Z, Fang H, Li H, Zhu F, Chang F. Tumor necrosis factor-α small interfering RNA alveolar epithelial cell-targeting nanoparticles reduce lung injury in C57BL/6J mice with sepsis. J Int Med Res 2021;49:300060520984652. [PMID: 33435767 DOI: 10.1177/0300060520984652] [Reference Citation Analysis]
47 Schinkel M, Virk HS, Nanayakkara PWB, van der Poll T, Wiersinga WJ. What Sepsis Researchers Can Learn from COVID-19. Am J Respir Crit Care Med 2021;203:125-7. [PMID: 33125253 DOI: 10.1164/rccm.202010-4023LE] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Peng Y, Wu Q, Zhou Q, Yang Z, Yin F, Wang L, Chen Q, Feng C, Ren X, Liu T. Identification of Immune-Related Genes Concurrently Involved in Critical Illnesses Across Different Etiologies: A Data-Driven Analysis. Front Immunol 2022;13:858864. [DOI: 10.3389/fimmu.2022.858864] [Reference Citation Analysis]
49 Leijte GP, Rimmelé T, Kox M, Bruse N, Monard C, Gossez M, Monneret G, Pickkers P, Venet F. Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes. Crit Care 2020;24:110. [PMID: 32192532 DOI: 10.1186/s13054-020-2830-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
50 Wang LX, Ren C, Yao RQ, Luo YN, Yin Y, Wu Y, Dong N, Zhu XM, Yao YM. Sestrin2 protects against lethal sepsis by suppressing the pyroptosis of dendritic cells. Cell Mol Life Sci 2021;78:8209-27. [PMID: 34741186 DOI: 10.1007/s00018-021-03970-z] [Reference Citation Analysis]
51 Peters-Sengers H, Butler JM, Uhel F, Schultz MJ, Bonten MJ, Cremer OL, Scicluna BP, van Vught LA, van der Poll T; MARS consortium. Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med 2022;48:92-102. [PMID: 34902047 DOI: 10.1007/s00134-021-06574-0] [Reference Citation Analysis]
52 Lu G, Zhou J, Yang T, Li J, Jiang X, Zhang W, Gu S, Wang J. Landscape of Metabolic Fingerprinting for Diagnosis and Risk Stratification of Sepsis. Front Immunol 2022;13:883628. [PMID: 35663956 DOI: 10.3389/fimmu.2022.883628] [Reference Citation Analysis]
53 Shah A, Oczkowski S, Aubron C, Vlaar AP, Dionne JC; ESICM Transfusion Task Force. Transfusion in critical care: Past, present and future. Transfus Med 2020;30:418-32. [PMID: 33207388 DOI: 10.1111/tme.12738] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Pereverzeva L, Uhel F, Peters Sengers H, Cremer OL, Schultz MJ, Bonten MMJ, Scicluna BP, van der Poll T; MARS consortium. Association between delay in intensive care unit admission and the host response in patients with community-acquired pneumonia. Ann Intensive Care 2021;11:142. [PMID: 34585271 DOI: 10.1186/s13613-021-00930-5] [Reference Citation Analysis]